The European Patent Office (EPO) has published patent application EP2026028770A1, detailing a cytochrome P450 protein or an active fragment thereof. This publication, dated March 18, 2026, falls under the International Patent Classification C12N (Microbiology; Enzymes; Mutants thereof). The application is designated for several European countries, including Germany, France, and the United Kingdom.

This is a patent publication, not a regulatory rule or guidance. It signifies the disclosure of an invention related to biotechnology and pharmaceuticals. Companies operating in these sectors, particularly those involved in enzyme technology or drug development, should note this publication for potential intellectual property landscape awareness. No immediate compliance actions are required based solely on this patent publication.